Literature DB >> 26889253

Association of antibiotic resistance with SHV-12 extended-spectrum β-lactamase in Enterobacter cloacae.

Jun Liu1, Guo-Ming Li1, Li-Yao Lin2, Xia-Lei Wu3, Shao-Long Huang4, Yong Zhou4, Zu-Guo Zhao1.   

Abstract

The association between antibiotic resistance and SHV-12 extended-spectrum β-lactamase (ESBL) in Enterobacter cloacae remains unknown. The aim of the present study was to investigate the prevalence of both chromosome- and plasmid-borne SHV-12 ESBL genes in Enterobacter cloacae. Transmission of the SHV-12 ESBL gene was explored, and the risk factors for antibiotic resistance in E. cloacae were analyzed. Polymerase chain reaction (PCR) results showed that 58 out of the 100 isolates carried the SHV-12 ESBL gene: 34.48% of them occurred in the chromosome, 48.28% were plasmid-borne and 17.24% appeared in both. Enterobacterial repetitive intergenic consensus-PCR tests detected 82 chromosomal genotypes. Conjugation assays showed that 70.00% of plasmid-borne SHV-12 ESBL genes were successfully transconjugated into E. coli C600 and that the antibiotic resistance phenotype of E. cloacae was partially (84%) or completely (10%) transferred. A significantly higher SHV-12 ESBL detection rate was found in patients with underlying conditions and/or complications compared with those without (P<0.05). The detection of SHV-12 ESBL-producing E. cloacae from vertical transmission varied significantly across clinical departments and age groups (P<0.05), with the highest rates in the intensive care unit and the group of patients aged ≥60 years. The present results indicate that the location and transmission efficiency of SHV-12 ESBL are closely correlated with the antibiotic resistance of E. cloacae.

Entities:  

Keywords:  Enterobacter cloacae; Phenotype; SHV-12; enterobacterial repetitive intergenic consensus-polymerase chain reaction; extended spectrum β-lactamases

Year:  2015        PMID: 26889253      PMCID: PMC4727147          DOI: 10.3892/etm.2015.2851

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  24 in total

1.  Emergence of VIM-4- and SHV-12-producing Enterobacter cloacae in a neonatal intensive care unit.

Authors:  Emese Juhász; Laura Jánvári; Akos Tóth; Ivelina Damjanova; András Nobilis; Katalin Kristóf
Journal:  Int J Med Microbiol       Date:  2012-06-20       Impact factor: 3.473

2.  Bacteremia due to extended-spectrum-beta-lactamase-producing Enterobacter cloacae: role of carbapenem therapy.

Authors:  Ching-Chi Lee; Nan-Yao Lee; Jing-Jou Yan; Hsin-Chun Lee; Po-Lin Chen; Chia-Ming Chang; Chi-Jung Wu; Nai-Ying Ko; Li-Rong Wang; Chih-Hsien Chi; Wen-Chien Ko
Journal:  Antimicrob Agents Chemother       Date:  2010-06-14       Impact factor: 5.191

Review 3.  Enterobacter cloacae complex: clinical impact and emerging antibiotic resistance.

Authors:  Maria Lina Mezzatesta; Floriana Gona; Stefania Stefani
Journal:  Future Microbiol       Date:  2012-07       Impact factor: 3.165

4.  Preservation of integron types among Enterobacteriaceae producing extended-spectrum beta-lactamases in a Spanish hospital over a 15-year period (1988 to 2003).

Authors:  Elisabete Machado; Joana Ferreira; Angela Novais; Luísa Peixe; Rafael Cantón; Fernando Baquero; Teresa M Coque
Journal:  Antimicrob Agents Chemother       Date:  2007-04-02       Impact factor: 5.191

5.  Detection of TEM & SHV genes in Escherichia coli & Klebsiella pneumoniae isolates in a tertiary care hospital from India.

Authors:  Jyoti Sharma; Meera Sharma; Pallab Ray
Journal:  Indian J Med Res       Date:  2010-09       Impact factor: 2.375

6.  Microbiologic and clinical implications of bacteremia due to extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae with or without plasmid-mediated AmpC beta-lactamase DHA-1.

Authors:  Chen-Hsiang Lee; Lin-Hui Su; Chia-Chin Li; Chun-Chih Chien; Ya-Fen Tang; Jien-Wei Liu
Journal:  Antimicrob Agents Chemother       Date:  2010-09-20       Impact factor: 5.191

7.  Molecular characterization and antimicrobial susceptibility of extended-spectrum {beta}-lactamase-producing Enterobacteriaceae isolates at a tertiary-care centre in Monterrey, Mexico.

Authors:  Elvira Garza-González; Sandra Iveth Mendoza Ibarra; Jorge M Llaca-Díaz; Gloria M Gonzalez
Journal:  J Med Microbiol       Date:  2010-10-07       Impact factor: 2.472

8.  Spread of plasmids containing the bla(VIM-1) and bla(CTX-M) genes and the qnr determinant in Enterobacter cloacae, Klebsiella pneumoniae and Klebsiella oxytoca isolates.

Authors:  Elisenda Miró; Concha Segura; Ferran Navarro; Lluisa Sorlí; Pere Coll; Juan P Horcajada; Francisco Alvarez-Lerma; Margarita Salvadó
Journal:  J Antimicrob Chemother       Date:  2010-01-20       Impact factor: 5.790

9.  Molecular characterization of extended-spectrum beta-lactamases produced by clinical isolates of Enterobacter cloacae from a Teaching Hospital in China.

Authors:  Gang Liu; Bao-Dong Ling; Yun Zeng; Li Lin; Yong-En Xie; J Lei
Journal:  Jpn J Infect Dis       Date:  2008-07       Impact factor: 1.362

10.  Detection of new SHV-12, SHV-5 and SHV-2a variants of extended spectrum beta-lactamase in Klebsiella pneumoniae in Egypt.

Authors:  Enas A Newire; Salwa F Ahmed; Brent House; Esmeralda Valiente; Guillermo Pimentel
Journal:  Ann Clin Microbiol Antimicrob       Date:  2013-07-18       Impact factor: 3.944

View more
  2 in total

1.  Antibacterial potential of Forsythia suspensa polysaccharide against resistant Enterobacter cloacae with SHV-12 extended-spectrum β-lactamase (ESBL).

Authors:  Jun Liu; Liyao Lin; Zhen Jia; Jing Chen; Zuguo Zhao; Yi Zhao; Zhujin Xu; Zhen Guo
Journal:  J Cell Mol Med       Date:  2020-06-25       Impact factor: 5.310

2.  Antimicrobial susceptibility and molecular epidemiology of clinical Enterobacter cloacae bloodstream isolates in Shanghai, China.

Authors:  Su Wang; Shu-Zhen Xiao; Fei-Fei Gu; Jin Tang; Xiao-Kui Guo; Yu-Xing Ni; Jie-Ming Qu; Li-Zhong Han
Journal:  PLoS One       Date:  2017-12-15       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.